Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 2
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYale University
About this trial
This study is stage 2, round 2 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
Eligibility criteria
Qualifiers
Emergency department patient
18 years of age or older
Moderate to severe opioid use disorder
Disqualifiers
Under 18 years of age
Pregnant
Currently receiving medication for opioid use disorder
Trial design
Treatments tested in this trial
- Refined EMBED CDS
- Provider alert to order consultation with addiction counselor
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Yale University
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov